Market Research Logo

Global Drugs for Osteoarthritis Pain Market Size, Status and Forecast 2025

Global Drugs for Osteoarthritis Pain Market Size, Status and Forecast 2025

This report studies the Drugs for Osteoarthritis Pain market status and outlook of global and major regions, from angles of players, regions, product and end Application/industries; this report analyzes the top players in global and major regions, and splits the Drugs for Osteoarthritis Pain market by product and Application/end industries.

The Drugs for Osteoarthritis Pain are expected to grow at a CAGR of 5.72% from 7439.2million USD in 2017 to reach 11610.4 million USD by 2025 in global market.

The major players in global Drugs for Osteoarthritis Pain market include
Pfizer
Johnson & Johnson
GlaxoSmithKline
Bayer
Eli Lilly
Novartis
Sanofi
Horizon Pharma
Abbott
Mylan
Daiichi Sankyo
TEVA
Almatica Pharma
Astellas Pharma
Tide Pharmaceutical
Iroko Pharmaceuticals
Hengrui Pharmaceutical
Abiogen Pharma

Geographically, this report is segmented into several key Regions, with evenue, market share and growth rate of Drugs for Osteoarthritis Pain in these regions, from 2013 to 2025 (forecast), covering
North America
Europe
Japan
China
RoA (Rest of Asia)
RoW (Rest of World)

On the basis of product, the Drugs for Osteoarthritis Pain market is primarily split into
Oral
Injection
External

On the basis on the end users/applications, this report covers
Medical Care
Personal Care


1 Industry Overview
1.1 Drugs for Osteoarthritis Pain Market Overview
1.1.1 Drugs for Osteoarthritis Pain Product Scope
1.1.2 Market Status and Outlook
1.2 Global Drugs for Osteoarthritis Pain Market Size and Analysis by Regions (2013-2018)
1.2.1 North America Drugs for Osteoarthritis Pain Market Status and Outlook
1.2.2 Europe Drugs for Osteoarthritis Pain Market Status and Outlook
1.2.3 Japan Drugs for Osteoarthritis Pain Market Status and Outlook
1.2.4 China Drugs for Osteoarthritis Pain Market Status and Outlook
1.2.5 RoA Drugs for Osteoarthritis Pain Market Status and Outlook
1.2.6 RoW Drugs for Osteoarthritis Pain Market Status and Outlook
1.3 Classification of Drugs for Osteoarthritis Pain by Product
1.3.1 Global Drugs for Osteoarthritis Pain Revenue and Growth Comparison by Product (2013-2025)
1.3.2 Global Drugs for Osteoarthritis Pain Revenue (Million USD) Market Share by Product in 2017
1.3.3 Oral
1.3.4 Injection
1.3.5 External
1.4 Drugs for Osteoarthritis Pain Market by End Users/Application
1.4.1 Medical Care
1.4.2 Personal Care
1.5 Macroscopic Indicator
1.5.1 GDP for Major Regions
1.5.2 Population and Labor Considered for Forecast
1.5.3 Disposable Income Considered for Forecast
2 Global Drugs for Osteoarthritis Pain Competition Analysis by Players
2.1 Global Drugs for Osteoarthritis Pain Market Size (Million USD) by Players
2.2 Competitive Status
3 Analysis of Drugs for Osteoarthritis Pain Industry Key Playerrs
3.1 Pfizer
3.1.1 Company Profile
3.1.2 Product Information
3.1.3 Revenue and Gross Margin
3.2 Johnson & Johnson
3.2.1 Company Profile
3.2.2 Product Information
3.2.3 Revenue and Gross Margin
3.3 GlaxoSmithKline
3.3.1 Company Profile
3.3.2 Product Information
3.3.3 Revenue and Gross Margin
3.4 Bayer
3.4.1 Company Profile
3.4.2 Product Information
3.4.3 Revenue and Gross Margin
3.5 Eli Lilly
3.5.1 Company Profile
3.5.2 Product Information
3.5.3 Revenue and Gross Margin
3.6 Novartis
3.6.1 Company Profile
3.6.2 Product Information
3.6.3 Revenue and Gross Margin
3.7 Sanofi
3.7.1 Company Profile
3.7.2 Product Information
3.7.3 Revenue and Gross Margin
3.8 Horizon Pharma
3.8.1 Company Profile
3.8.2 Product Information
3.8.3 Revenue and Gross Margin
3.9 Abbott
3.9.1 Company Profile
3.9.2 Product Information
3.9.3 Revenue and Gross Margin
3.10 Mylan
3.10.1 Company Profile
3.10.2 Product Information
3.10.3 Revenue and Gross Margin
3.11 Daiichi Sankyo
3.11.1 Company Profile
3.11.2 Product Information
3.11.3 Revenue and Gross Margin
3.12 TEVA
3.12.1 Company Profile
3.12.2 Product Information
3.12.3 Revenue and Gross Margin
3.13 Almatica Pharma
3.13.1 Company Profile
3.13.2 Product Information
3.13.3 Revenue and Gross Margin
3.14 Astellas Pharma
3.14.1 Company Profile
3.14.2 Product Information
3.14.3 Revenue and Gross Margin
3.15 Tide Pharmaceutical
3.15.1 Company Profile
3.15.2 Product Information
3.15.3 Revenue and Gross Margin
3.16 Iroko Pharmaceuticals
3.16.1 Company Profile
3.16.2 Product Information
3.16.3 Revenue and Gross Margin
3.17 Hengrui Pharmaceutical
3.17.1 Company Profile
3.17.2 Product Information
3.17.3 Revenue and Gross Margin
3.18 Abiogen Pharma
3.18.1 Company Profile
3.18.2 Product Information
3.18.3 Revenue and Gross Margin
4 Global Drugs for Osteoarthritis Pain Market Size by Product and Application (2013-2018)
4.1 Global Drugs for Osteoarthritis Pain Market Size by Product (2013-2018)
4.2 Global Drugs for Osteoarthritis Pain Market Size by Application (2013-2018)
4.3 Top Consumer / End Users of Drugs for Osteoarthritis Pain
5 North America Drugs for Osteoarthritis Pain Development Status and Outlook
5.1 North America Drugs for Osteoarthritis Pain Market Size (2013-2018)
5.2 North America Drugs for Osteoarthritis Pain Market Size and Market Share by Players
5.3 North America Drugs for Osteoarthritis Pain Market Size by Application (2013-2018)
6 Europe Drugs for Osteoarthritis Pain Development Status and Outlook
6.1 Europe Drugs for Osteoarthritis Pain Market Size (2013-2018)
6.2 Europe Drugs for Osteoarthritis Pain Market Size and Market Share by Players (2017-2018)
6.3 Europe Drugs for Osteoarthritis Pain Market Size by Application (2013-2018)
7 Japan Drugs for Osteoarthritis Pain Development Status and Outlook
7.1 Japan Drugs for Osteoarthritis Pain Market Size (2013-2018)
7.2 Japan Drugs for Osteoarthritis Pain Market Size and Market Share by Players (2017-2018)
7.3 Japan Drugs for Osteoarthritis Pain Market Size by Application (2013-2018)
8 China Drugs for Osteoarthritis Pain Development Status and Outlook
8.1 China Drugs for Osteoarthritis Pain Market Size and Forecast (2013-2018)
8.2 China Drugs for Osteoarthritis Pain Market Size and Market Share by Players (2017-2018)
8.3 China Drugs for Osteoarthritis Pain Market Size by Application (2013-2018)
9 RoA Drugs for Osteoarthritis Pain Development Status and Outlook
9.1 RoA Drugs for Osteoarthritis Pain Market Size and Forecast (2013-2018)
9.2 RoA Drugs for Osteoarthritis Pain Market Size and Market Share by Players (2017-2018)
9.3 RoA Drugs for Osteoarthritis Pain Market Size by Application (2013-2018)
10 RoW Drugs for Osteoarthritis Pain Development Status and Outlook
10.1 RoW Drugs for Osteoarthritis Pain Market Size and Forecast (2013-2018)
10.2 RoW Drugs for Osteoarthritis Pain Market Size and Market Share by Players (2017-2018)
10.3 RoW Drugs for Osteoarthritis Pain Market Size by Application (2013-2018)
11 Market Forecast by Regions, Product and Application (2019-2025)
11.1 Global Drugs for Osteoarthritis Pain Market Size (Million USD) by Regions (2019-2025)
11.1.1 North America Drugs for Osteoarthritis Pain Revenue and Growth Rate (2019-2025)
11.1.2 Europe Drugs for Osteoarthritis Pain Revenue and Growth Rate (2019-2025)
11.1.3 China Drugs for Osteoarthritis Pain Revenue and Growth Rate (2019-2025)
11.1.4 Japan Drugs for Osteoarthritis Pain Revenue and Growth Rate (2019-2025)
11.1.5 RoW Drugs for Osteoarthritis Pain Revenue and Growth Rate (2019-2025)
11.1.6 RoA Drugs for Osteoarthritis Pain Revenue and Growth Rate (2019-2025)
11.2 Global Drugs for Osteoarthritis Pain Market Size by Application (2019-2025)
11.3 Global Drugs for Osteoarthritis Pain Market Size by Product (2019-2025)
12 Drugs for Osteoarthritis Pain Market Dynamics
12.1 Osteoarthritis Analysis
12.1.1 Overview
12.1.2 Symptoms
12.2 Drugs for Osteoarthritis Pain Challenge and Risk
12.3 Drugs for Osteoarthritis Pain Market Driving Force
13 Factors Influencing
13.1 Macro-Economic Factors
13.2 Price Trend of Key Industrial Raw Material
14 Research Finding /Conclusion
15 Methodology and Data Source
15.1 Methodology/Research Approach
15.1.1 Research Programs/Design
15.1.2 Market Size Estimation
15.1.3 Market Breakdown and Data Triangulation
15.2 Data Source
15.2.1 Secondary Sources
15.2.2 Primary Sources
15.3 Author List
15.4 Disclaimer
List of Tables and Figures
Figure Drugs of Osteoarthritis Pain
Figure Global Drugs for Osteoarthritis Pain Market Size (Million USD) Status and Outlook (2013-2025)
Table Global Market Drugs for Osteoarthritis Pain Revenue (Million USD) Comparison by Regions 2013-2025
Figure Global Drugs for Osteoarthritis Pain Market Share by Regions (2013-2018)
Figure North America Drugs for Osteoarthritis Pain Market Size (Million USD) and Growth Rate (2013-2018)
Figure Europe Drugs for Osteoarthritis Pain Market Size (Million USD) and Growth Rate (2013-2018)
Figure Japan Drugs for Osteoarthritis Pain Market Size (Million USD) and Growth Rate (2013-2018)
Figure China Drugs for Osteoarthritis Pain Market Size (Million USD) and Growth Rate (2013-2018)
Figure RoA Drugs for Osteoarthritis Pain Market Size (Million USD) and Growth Rate (2013-2018)
Figure RoW Drugs for Osteoarthritis Pain Market Size (Million USD) and Growth Rate (2013-2018)
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) and Growth Rate Comparison by Product (2013-2025)
Figure Global Drugs for Osteoarthritis Pain Revenue (Million USD) Comparison by Product (2013-2025)
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share by Product in 2017
Figure Oral Market Size (Million USD) and Growth Rate (2013-2018)
Figure Injection Market Size (Million USD) and Growth Rate (2013-2018)
Figure External Market Size (Million USD) and Growth Rate (2013-2018)
Figure Global Drugs for Osteoarthritis Pain Market Size (Million USD) Comparison by Application (2013-2025)
Figure Global Drugs for Osteoarthritis Pain Market Share by Application
Figure Drugs for Osteoarthritis Pain Market Size (Million USD) and Growth Rate in Medical Care (2013-2018)
Figure Drugs for Osteoarthritis Pain Market Size (Million USD) and Growth Rate in Personal Care (2013-2018)
Figure GDP for Major Regions in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Figure Forecast of Global Middle-Class Population, 2015 to 2030
Figure Fertility Rates per Woman, 1970 to 2015
Figure Average Years of Schooling of the Adult Population
Figure Household Disposable Income Gross adjusted, US dollars/capita, 2016
Figure Household Spending Total, Million US dollars, 2015
Figure Net National Income Total, US dollars/capita, 2017
Table Global Drugs for Osteoarthritis Pain Revenue (Million USD) by Players (2017-2018)
Table Global Drugs for Osteoarthritis Pain Revenue Market Share by Players (2017-2018)
Figure Global Drugs for Osteoarthritis Pain Market Size Share by Players in 2017
Figure Global Drugs for Osteoarthritis Pain Market Size Share by Players in 2018
Figure Global Top 5 Players Drugs for Osteoarthritis Pain Market Share in 2017
Figure Global Top 10 Players Drugs for Osteoarthritis Pain Market Share in 2017
Table Pfizer Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of Pfizer
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of Pfizer 2017-2018
Table Johnson & Johnson Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of Johnson & Johnson
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of Johnson & Johnson 2017-2018
Table GlaxoSmithKline Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of GlaxoSmithKline
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of GlaxoSmithKline 2017-2018
Table Bayer Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of Bayer
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of Bayer 2017-2018
Table Eli Lilly Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of Eli Lilly
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of Eli Lilly 2017-2018
Table Novartis Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of Novartis
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of Novartis 2017-2018
Table Sanofi Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of Sanofi
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of Sanofi 2017-2018
Table Horizon Pharma Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of Horizon Pharma
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of Horizon Pharma 2017-2018
Table Abbott Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of Abbott
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of Abbott 2017-2018
Table Mylan Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of Mylan
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of Mylan 2017-2018
Table Daiichi Sankyo Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of Daiichi Sankyo
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of Daiichi Sankyo 2017-2018
Table TEVA Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of TEVA
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of TEVA 2017-2018
Table Almatica Pharma Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of Almatica Pharma
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of Almatica Pharma 2017-2018
Table Astellas Pharma Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of Astellas Pharma
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of Astellas Pharma 2017-2018
Table Tide Pharmaceutical Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of Tide Pharmaceutical
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of Tide Pharmaceutical 2017-2018
Table Iroko Pharmaceuticals Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of Iroko Pharmaceuticals
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of Iroko Pharmaceuticals 2017-2018
Table Hengrui Pharmaceutical Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of Hengrui Pharmaceutical
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of Hengrui Pharmaceutical 2017-2018
Table Abiogen Pharma Company Profile
Figure Drugs for Osteoarthritis Pain Product Picture of Abiogen Pharma
Table Drugs for Osteoarthritis Pain Revenue (M USD) and Gross Margin of Abiogen Pharma 2017-2018
Table Global Drugs for Osteoarthritis Pain Market Size by Product (2013-2018)
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share by Product (2013-2018)
Figure Global Drugs for Osteoarthritis Pain Market Size Share by Product in 2017
Table Global Drugs for Osteoarthritis Pain Market Size by Application (2013-2018)
Figure Global Drugs for Osteoarthritis Pain Revenue Market Share by Application (2013-2018)
Figure Global Drugs for Osteoarthritis Pain Market Size Share by Application in 2017
Table Top Consumer / End Users of Drugs for Osteoarthritis Pain
Figure North America Drugs for Osteoarthritis Pain Market Size and Growth Rate (2013-2018)
Table North America Drugs for Osteoarthritis Pain Market Size by Players (2017-2018)
Figure North America Drugs for Osteoarthritis Pain Market Size Share by Players in 2017
Table North America Drugs for Osteoarthritis Pain Market Size by Application (2013-2018)
Figure North America Drugs for Osteoarthritis Pain Market Size Share by Application in 2017
Figure Europe Drugs for Osteoarthritis Pain Market Size and Growth Rate

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report